Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 30 June 2023
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
57
Renminbi (CNY)
17
Euro (EUR)
11
Swiss franc (CHF)
8
Indian rupee (INR)
4
Other currencies (CAD, DKK, GBP, HDK, SEK)
3
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
35
Public (from private) companies
26
Public companies
18
Cash and cash equivalents
11
Funds
9
Other assets
1
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
41
Products on the market
24
Preclinical
7
Phase I
7
Phase II
15
Phase III
6
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
25
Synthetic biology
19
Oncology
15
Digital Health
10
Central nervous system
10
Immunology/Inflammation
8
Orphan diseases
7
Medical technology / diagnostics
6
#672a66
#49753d
#21659a
#eabc00
#60504c
#03375e
#6fa231
#d997b6
#cc5d3f
#B7D4D8